Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member constituency answering member printed answering member printed answering member label answering member attachment file name title
tabling member	label

Search

390600

registered interest
date	16/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Anaemia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how they propose to alert medical practitioners to the severe and irreversible nerve damage that can occur when pernicious anaemia is misdiagnosed.
tabling member printed	The Countess of Mar
uin	HL1540
answer	answer is ministerial correction date of answer 24/07/2015 answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p> answering member printed Lord Prior of Brampton question first answered 24/07/2015 13:21:19 question first ministerially corrected 14/10/2015 11:21:19 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia previous answer version 17460 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia
tabling member	1861 label Biography information for The Countess of Mar

389070

registered interest
date	10/07/2015
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Secure Colleges: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, pursuant to the Answer of 9 July 2015 to Question 5710, what the cost to the public purse has been of his Department's spending on the Secure College programme to date.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	6553
answer	answer is ministerial correction date of answer 15/07/2015 answer text <p>Total <ins class="ministerial">estimated </ins>spend on the Secure College pathfinder was £5.88m. This includes <ins class="ministerial">an estimated </ins>£1.56m resource<ins class="ministerial"> spend</ins> (mainly expenditure on staff pay and procurement) and <ins class="ministerial">an estimated </ins>£4.32m capital <ins class="ministerial">spend </ins>(mainly design fees and site preparation costs). <ins class="ministerial">These figures are subject to review by the National Audit Office in January 2016.</ins></p><br /><p>All services were procured through a competitive process and assessed as providing value for money to the department. The design work produced for the pathfinder could be used or adapted for alternative provision, and the prepared site at Glen Parva could be used for a range of developments.</p> answering member constituency South West Bedfordshire answering member printed Andrew Selous question first answered 15/07/2015 13:13:22 question first ministerially corrected 07/12/2015 18:07:21 answering member 1453 label Biography information for Andrew Selous previous answer version 15194 answering member constituency South West Bedfordshire answering member printed Andrew Selous answering member 1453 label Biography information for Andrew Selous
tabling member	1516 label Biography information for Andy Slaughter

388611

registered interest
date	08/07/2015
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	British Nationals Abroad: Homicide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, how many British nationals were murdered abroad in each year since 2010; and in which countries those deaths took place.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	6146
answer	answer is ministerial correction date of answer 14/07/2015 answer text <p>The Foreign and Commonwealth Office only captures information about cases that come to our attention, rather than holding definitive information on the total number of UK nationals who are victims of murder and manslaughter overseas.</p><p>The FCO has provided assistance to the following number of cases recorded as murder and manslaughter in each of the last five years:</p><p>2010 <del class="ministerial">46</del><ins class="ministerial">68</ins><br />2011 <del class="ministerial">70</del><ins class="ministerial">78</ins><br />2012 <del class="ministerial">59</del><ins class="ministerial">53</ins><br />2013 <del class="ministerial">76</del><ins class="ministerial">78</ins><br />2014 <del class="ministerial">89</del><ins class="ministerial">84</ins><br />2015 <del class="ministerial">67 (up to and including July 2015)</del><ins class="ministerial">88</ins>.</p><p>In January 2015, the FCO established a new dedicated team to lead on murder and manslaughter cases. These cases have occurred throughout the world in the past five years. Since January, deaths have occurred in Afghanistan, Brazil, Canada, Denmark, Egypt, France, Ghana, India, Kenya, Mexico, New Zealand, Pakistan, Philippines, South Africa, South Sudan, Spain, Switzerland, Thailand, Trinidad &amp; Tobago, Tunisia, USA, and Zambia.</p><p> </p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood previous answer version 13825 answering member constituency Rochford and Southend East answering member printed James Duddridge answering member 1559 14118 answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood answering member 1487 label Biography information for Mr Tobias Ellwood question first answered 14/07/2015 15:57:15 question first ministerially corrected 16/03/2016 10:24:42 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	4122 label Biography information for Alex Cunningham

387883

registered interest
date	06/07/2015
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Concentrix
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, which contracts placed out to tender by (a) his Department and (b) HM Courts and Tribunals Service have been bid on by Synnex Concentrix.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	5624
answer	answer is ministerial correction date of answer 30/07/2015 answer text <p><ins class="ministerial">As of the 7<sup>th</sup> July, the following contracts the Department, including HM Courts and Tribunals Service currently have out to tender are,</ins></p><p>PQ 5623</p><p>1. Professional Services, Evaluation of Sentencing Council Guidelines.</p><p> </p><p>2. HMP Holloway Fire Safety Improvements.</p><p> </p><p>3. Reducing Reoffending, Provision of three Risk assessments at</p><p>HMP Swaleside, East Sutton Park and Stanford Hill.</p><p> </p><p>4. Operational Goods, Supply of Portable Mobile Phone Detection Equipment.</p><p> </p><p>5. Reducing Reoffending, Retender of Provision for 1 forensic psychology risk assessment at</p><p>HMP Leyhill,</p><p> </p><p>6. HMP Wandsworth Demolition of Laundry.</p><p> </p><p>7. Reducing Reoffending, Provision of sixteen forensic psychology risk assessments at HMP Frankland.</p><p> </p><p>8. Compliance and Enforcement Service, (Court Fines).</p><p> </p><p>9. Transforming Youth Custody – Secure Training Centre.</p><p> </p><p>10. Criminal Justice System – Efficiencies.</p><p> </p><p>11. Professional Services – To implement a specialist financial services framework.</p><p> </p><p>PQ 5624</p><p> </p><p>I can confirm that Synnex Concentrix has been announced as the preferred bidder for court enforcements.</p><p> </p><p>At this point, we are unable to disclose which suppliers have been involved in the other competitions listed above due to procurement competition rules and regulations.</p> answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara question first answered 30/07/2015 11:43:02 question first ministerially corrected 31/07/2015 10:18:51 answering member 1496 label Biography information for Shailesh Vara previous answer version 18840 answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara answering member 1496 label Biography information for Shailesh Vara
tabling member	304 label Biography information for Mr Roger Godsiff

386702

registered interest
date	30/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average cost to the taxpayer is of training someone to become a doctor in the UK.
tabling member constituency	East Yorkshire
tabling member printed	Sir Greg Knight
uin	4761
answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>The Department does not hold information on the average cost to the taxpayer of training someone to become a doctor in the United Kingdom.</p><br /> <br /> <br /><p>The Personal Social Services Research Unit at the University of Kent estimates within their report ‘Unit Costs of Health and Social Care 2014’, published March 2014, that the average cost in <ins class="ministerial">2013/14 </ins><del class="ministerial">2014/15</del> of training to become a general practitioner is £485,390 with the consultant training cost being £726,551. These figures reflect the pre-registration costs of tuition, living expenses/lost production and clinical placements and the post-graduate costs of tuition and replacement costs not the average cost to the taxpayer.</p><br /> answering member constituency Ipswich answering member printed Ben Gummer question first answered 08/07/2015 13:27:38 question first ministerially corrected 02/11/2015 11:19:49 answering member 3988 label Biography information for Ben Gummer previous answer version 12875 answering member constituency Ipswich answering member printed Ben Gummer answering member 3988 label Biography information for Ben Gummer
tabling member	1200 label Biography information for Sir Greg Knight

383716

registered interest
date	18/06/2015
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Secure Colleges: Leicestershire
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the costs that will have been incurred in the event that the planned provision of a secure college on the Glen Parva site does not go ahead.
tabling member printed	Lord Beecham
uin	HL624
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p><ins class="ministerial">The Coalition government legislated for secure colleges and we are now considering the next steps.</ins></p><br /><p><ins class="ministerial">Estimated s</ins><del class="ministerial">S</del>pend up to and including 30 April 2015 on the Secure College pathfinder was £1.56m resource (mainly expenditure on staff pay and procurement) and £4.04m capital (mainly design fees and site preparation costs).<ins class="ministerial"> These figures are subject to review by the National Audit Office in January 2016.</ins></p><br /><p>No additional costs would be incurred in the event that the pathfinder did not go ahead. The design work produced for the pathfinder could be used or adapted for various other forms of adult or youth custody. The prepared site at Glen Parva could be used for a range of developments.</p> answering member printed Lord Faulks question first answered 02/07/2015 15:59:41 question first ministerially corrected 07/12/2015 16:13:38 answering member 4183 label Biography information for Lord Faulks previous answer version 10857 answering member printed Lord Faulks answering member 4183 label Biography information for Lord Faulks
tabling member	4181 label Biography information for Lord Beecham

168664

registered interest
date	08/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many abortions were refused on the grounds on coercion in the last year for which records are available.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	217766
answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Department does <ins class="ministerial">not </ins>hold this information.</p><p> </p><p> </p><p> </p><p>We take the issue of coercion seriously and staff working in abortion clinics are experienced and highly skilled in discussing sensitive issues with women and identifying whether there is any coercion or other risks to the woman.</p><p> </p><p> </p><p> </p><p>Women who present for an abortion will always have the opportunity to speak to a health professional on their own at some point during the consultation. Pathways should be in place to refer women to specialised services if coercion is identified.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/12/2014 16:55:05 question first ministerially corrected 15/12/2014 17:10:17 answering member 3918 label Biography information for Jane Ellison previous answer version 33589 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
tabling member	3998 label Biography information for Mark Menzies

167082

registered interest
date	01/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sickle Cell Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the annual cost to the NHS of treating sickle cell anaemia.
tabling member constituency	Wolverhampton South East
tabling member printed	Mr Pat McFadden
uin	216529
answer	answer is ministerial correction date of answer 08/12/2014 answer text <p>There are an estimated 250,000 people with <ins class="ministerial">the</ins> sickle cell <ins class="ministerial">trait</ins> <del class="ministerial">anaemia</del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.</p><p> </p><p> </p><p> </p><p>The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/12/2014 15:12:22 question first ministerially corrected 10/12/2014 16:29:44 answering member 3918 label Biography information for Jane Ellison previous answer version 32239 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
tabling member	1587 label Biography information for Pat McFadden

100887

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Asthma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	211918
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
tabling member	4026 label Biography information for Liz Kendall

100721

registered interest
date	23/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Osteoporosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	211732
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 29/10/2014 17:12:28 question first ministerially corrected 13/11/2014 10:22:56 answering member 4020 label Biography information for George Freeman previous answer version 25123 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
tabling member	4026 label Biography information for Liz Kendall